Premium
SITUATIONS CREATING ETHICAL STRESS
Author(s) -
Fox Richard M.
Publication year - 1981
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1981.tb135432.x
Subject(s) - medicine , drug , clinical trial , cancer , cancer therapy , intensive care medicine , animal testing , pharmacology , pathology , biology , ecology
When a new therapeutic procedure, be it either a cytotoxic drug, surgical operation or radiotherapeutic treatment, is introduced into cancer treatment, it generally requires a careful trial involving comparison with a standard or traditional therapy. The introduction of a new drug in cancer therapy is generally a complex matter, and involves several stages of testing. Such agents are identified as potential anticancer drugs on the basis of preclinical screening studies which involve animal tumour models, and the study of the efficacy of drugs on animal and human tumour cells in tissue culture.